4.9200
+0.0400
+(0.82%)
At close: January 10 at 8:07:46 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IUL.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Initiated | Aegis Capital: Buy | 7/13/2020 |
Related Tickers
RVMDW Revolution Medicines, Inc.
0.1700
-2.86%
ROVI.VI Laboratorios Farmaceuticos Rovi, S.A.
61.80
-1.12%
SPL.AX Starpharma Holdings Limited
0.1100
0.00%
CLDWW Calidi Biotherapeutics, Inc.
0.0091
+506.67%
PBM Psyence Biomedical Ltd.
1.7000
-7.61%
MGNX MacroGenics, Inc.
3.1800
-5.07%
COCP Cocrystal Pharma, Inc.
2.2100
-7.14%
RVMD Revolution Medicines, Inc.
41.78
-5.94%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
OCUL Ocular Therapeutix, Inc.
8.21
-7.44%